查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1908778

乳房摄影市场规模、份额和趋势分析报告：按技术、最终用途、地区和细分市场预测（2026-2033 年）

Breast Imaging Market Size, Share & Trends Analysis Report By Technology (Ionizing, Non Ionizing), By End Use (Hospitals, Breast Care Centers, Diagnostic Imaging Centers), By Region, And Segment Forecasts, 2026 - 2033
出版日期: | 出版商: Grand View Research | 英文 97 Pages | 商品交期: 2-10个工作天内

价格

乳房摄影诊断市场概况

全球乳房摄影成像市场预计到 2025 年价值 58.8 亿美元，预计到 2033 年将达到 120.3 亿美元。

预计从 2026 年到 2033 年，乳房影像市场将以 9.7% 的复合年增长率成长。乳癌发病率上升、乳房摄影影像领域的技术突破以及多家机构对乳癌筛检计画的投资等因素正在推动乳房摄影影像市场的成长。

根据世界癌症研究基金会（WCRF）的数据，预计到2030年，全球整体乳癌病例将达到约210万例。国际癌症研究机构（IARC）的一份新报告预测，到2050年，全球乳癌病例将增加38%，年死亡人数将增加68%。预计这一趋势将在预测期内推动乳房摄影影像市场的成长。

乳癌及其他乳房相关疾病发生率的不断上升预计将显着推动乳房摄影影像市场的扩张。根据美国国家乳癌基金会（National 乳癌 Cancer Foundation, Inc.）2025年6月发布的数据，预计美国约有八分之一的女性在一生中会被诊断出罹患乳癌。此外，国际癌症研究机构（IARC）预测，2022年至2050年间，美国乳癌发生率将成长27.8%，到2050年将达到约350,693例。癌症病例数量的显着增长预计将推动美国对乳房磁振造影（MRI）检查的需求。

技术创新正在推动乳房摄影市场的成长，而对更早期、更精准的癌症检测的需求不断增长，更是推动了这一成长。分子乳房摄影、人工智慧辅助诊断和高清乳房摄影显示等创新技术正在提升临床信心，并减少解读难题。随着医疗机构将精准医疗和筛检效率置于优先地位，这些先进工具的应用正在加速普及，并塑造乳癌检测和治疗的未来。

对混合成像系统开发的广泛研究蕴藏着巨大的成长机会，并有助于市场扩张。影像技术的最新发展趋势彻底革新了治疗的性质和方法。结合电脑断层扫描、MRI和PET扫描等多种影像方式来观察器官代谢资料和解剖特征变得日益重要。此外，这些整合成像方式提高了乳房摄影影像的品质、患者的舒适度并降低了辐射剂量。这些优势促使全球製造商致力于推出能够提高乳癌诊断灵敏度和准确性的新产品。例如，DeepHealth计划于2025年2月在欧洲市场推出其“诊断套件”，该套件提供了一个具有统一、工作流程优化的放射科工作空间的下一代PACS系统。该公司还计划扩大其人工智慧驱动的端到端乳房X光摄影诊断解决方案「SmartMammo」的普及范围，进一步将基于人工智慧的检测功能和临床决策支援整合到常规成像工作流程中。

目录

第一章调查方法和范围

第二章执行摘要

第三章乳房摄影诊断市场变数、趋势和范围

  • 市场谱系展望
    • 母市场展望
  • 市场动态
  • 乳房摄影市场分析工具
    • 产业分析：波特五力模型
    • PESTEL 分析

第四章乳房摄影诊断市场：依技术分類的估算与趋势分析

  • 全球乳房摄影诊断市场：技术变革分析
  • 全球乳房摄影诊断市场规模及趋势分析（依技术划分，2021-2033 年）
  • 电离
    • 全视野数位乳房摄影
    • 模拟乳房摄影
    • 正电子放射乳房摄影术
    • 电电阻扫描
    • 锥状射束CT
    • 正子断层扫描和电脑断层扫描
    • 3D乳房断层合成
    • MBI/BSGI
  • 非电离
    • MRI
    • 热成像
    • 超音波
    • 光学成像
    • 自动全乳超音波

第五章乳房摄影：依最终用途分類的估算与趋势分析

  • 全球乳房摄影影像市场：依最终用途分類的差异分析
  • 全球乳房摄影诊断市场规模及趋势分析（按最终用途划分），2021-2033年
  • 医院
    • 医院市场估计与预测（2021-2033）
  • 诊断影像中心
    • 诊断影像中心市场估计与预测（2021-2033）
  • 乳房护理中心
    • 乳房护理中心市场估计与预测（2021-2033）

第六章乳房摄影诊断市场：区域估算与趋势分析

  • 区域仪錶板
  • 市场规模、预测与趋势分析（2021-2033）
  • 北美洲
    • 美国
    • 加拿大
    • 墨西哥
  • 欧洲
    • 英国
    • 德国
    • 法国
    • 义大利
    • 西班牙
    • 丹麦
    • 瑞典
    • 挪威
  • 亚太地区
    • 日本
    • 印度
    • 中国
    • 韩国
    • 澳洲
    • 泰国
  • 拉丁美洲
    • 巴西
    • 阿根廷
  • 中东和非洲
    • 南非
    • 沙乌地阿拉伯
    • 阿拉伯聯合大公国
    • 科威特

第七章 竞争情势

  • 对主要市场参与企业近期趋势和影响的分析
  • 公司/竞争对手分类
    • 创新者
  • 供应商概况
    • 主要经销商和通路合作伙伴名单
    • Key customers
    • Global Key company market share analysis, 2024
    • GE HealthCare
    • Siemens Healthineers
    • Philips Healthcare
    • Hologic, Inc.
    • Fujifilm Holdings Corp.
    • SonoCine, Inc.
    • Toshiba Corporation（Canon Inc.）
    • Dilon Technologies, Inc.
    • SonoCine, Inc.
    • Aurora Imaging Technology, Inc.
  • 热力图分析/企业市场分析
  • 2025年企业市场占有率预测分析
  • 其他主要市场参与者名单
Product Code: 978-1-68038-146-7

Breast Imaging Market Summary

The global breast imaging market size was estimated at USD 5.88 billion in 2025 and is projected to reach USD 12.03 billion by 2033, growing at a CAGR of 9.7% from 2026 to 2033. Factors such as the rising prevalence of breast cancer, technological breakthroughs in the domain of breast imaging, and investment from several organizations in breast cancer screening programs drive the breast imaging market.

According to the World Cancer Research Fund (WCRF), by 2030, the number of cases of breast cancer is expected to reach about 2.1 million globally. According to a new report from the International Agency for Research on Cancer (IARC), breast cancer cases are expected to increase by 38 percent globally by 2050, with annual deaths from the disease projected to rise by 68 percent. This aspect is expected to contribute to the growth of the breast imaging market over the forecast period.

The growing prevalence of breast cancer and other breast-related abnormalities is expected to drive the expansion of the breast imaging market significantly. According to data published by the National Breast Cancer Foundation, Inc. in June 2025, approximately 1 in 8 women in the U.S. is expected to be diagnosed with breast cancer during their lifetime. In addition, projections from the International Agency for Research on Cancer estimate a 27.8% increase in breast cancer incidence in the U.S. between 2022 and 2050, with cases expected to reach approximately 350,693 by 2050. This substantial rise in cancer cases is anticipated to fuel the demand for breast magnetic resonance imaging procedures across the country.

Technological advancements are driving the growth of the breast imaging market, supported by increasing demand for earlier and more accurate cancer detection. Innovations such as molecular breast imaging, AI-assisted diagnostics, and enhanced breast imaging displays are improving clinical confidence and reducing interpretation challenges. As healthcare providers prioritize precision medicine and screening efficiency, these advanced tools continue to accelerate adoption and shape the future of breast cancer detection and care.

Widespread research in the development of hybrid imaging systems provides high growth opportunities and also aids the market growth. Recent developments in imaging technology have completely revolutionized the nature of treatment and how it is approached. To view the metabolic data and anatomical characteristics of the organs, it has become more crucial to combine imaging methods such as CT scans, MRIs, PET, and others. Furthermore, the quality of breast pictures, patient comfort, and patient dose have all been enhanced by these integrated imaging modalities. Thereby, owing to these advantages, manufacturers across the globe are concentrating more on the introduction of new products to improve the sensitivity and precision of breast cancer diagnostics. For instance, in February 2025, DeepHealth plans to introduce its Diagnostic Suite to the European market, offering a next-generation PACS system with a unified, workflow-optimized radiology workspace. The company also aims to expand access to SmartMammo, its AI-driven end-to-end mammography diagnostic solution, further integrating AI-enabled detection and clinical decision support into routine imaging workflows.

Global Breast Imaging Market Report Segmentation

This report forecasts revenue growth at global, regional, and country levels and provides an analysis on the latest industry trends in each of the sub-segments from 2021 to 2033. For this study, Grand View Research has segmented the global breast imaging market report based on technology, end use, and region:

  • Technology Outlook (Revenue, USD Million, 2021 - 2033)
  • Ionizing
    • Full-field Digital Mammography
    • Analog Mammography
    • Positron Emission Mammography
    • Electric Impedance Tomography
    • Cone-beam Computed Tomography
    • Positron Emission Tomography & Computed Tomography
    • 3D Breast Tomosynthesis
    • MBI/BSGI
  • Non Ionizing
    • MRI
    • Thermography
    • Ultrasound
    • Optical Imaging
    • Automated Whole-Breast Ultrasound
  • End Use Outlook (Revenue, USD Million, 2021 - 2033)
  • Hospitals
  • Breast Care Centers
  • Diagnostic Imaging Centers
  • Regional Outlook (Revenue, USD Million, 2021 - 2033)
  • North America
    • U.S.
    • Canada
    • Mexico
  • Europe
    • Germany
    • UK
    • France
    • Italy
    • Spain
    • Sweden
    • Denmark
    • Norway
  • Asia Pacific
    • Japan
    • China
    • India
    • Australia
    • South Korea
    • Thailand
  • Latin America
    • Brazil
    • Argentina
  • Middle East & Africa
    • South Africa
    • Saudi Arabia
    • UAE
    • Kuwait

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation & Scope
    • 1.1.1. Technology
    • 1.1.2. End use
    • 1.1.3. Regional scope
    • 1.1.4. Estimates and forecast timeline
  • 1.2. Research Methodology
  • 1.3. Information Procurement
    • 1.3.1. Purchased database
    • 1.3.2. GVR's internal database
    • 1.3.3. Secondary sources
    • 1.3.4. Primary research
    • 1.3.5. Details of primary research
  • 1.4. Information or Data Analysis
    • 1.4.1. Data analysis models
  • 1.5. Market Formulation & Validation
  • 1.6. Model Details
    • 1.6.1. Commodity flow analysis (Model 1)
      • 1.6.1.1. Approach 1: Commodity flow approach
    • 1.6.2. Volume price analysis (Model 2)
      • 1.6.2.1. Approach 2: Volume price analysis
  • 1.7. List of Secondary Sources
  • 1.8. List of Primary Sources
  • 1.9. Objectives
    • 1.9.1. Objective 1
    • 1.9.2. Objective 2

Chapter 2. Executive Summary

  • 2.1. Market Outlook
  • 2.2. Segment Outlook
  • 2.3. Competitive Insights

Chapter 3. Breast Imaging Market Variables, Trends & Scope

  • 3.1. Market Lineage Outlook
    • 3.1.1. Parent market outlook
  • 3.2. Market Dynamics
    • 3.2.1. Market driver analysis
      • 3.2.1.1. Growing prevalence of breast cancer
      • 3.2.1.2. Technological advancements in the field of breast imaging
      • 3.2.1.3. Investments and initiatives from various organizations in breast cancer screening campaigns
    • 3.2.2. Market restraint analysis
      • 3.2.2.1. Risk of adverse effects from radiation exposure
      • 3.2.2.2. High cost of imaging systems
    • 3.2.3. Market opportunity analysis
      • 3.2.3.1. Growing number of clinical trials
      • 3.2.3.2. Growing awareness of early detection
    • 3.2.4. Market challenge analysis
      • 3.2.4.1. Shortage of trained radiologists
  • 3.3. Breast Imaging Market Analysis Tools
    • 3.3.1. Industry Analysis - Porter's
      • 3.3.1.1. Bargaining power of suppliers
      • 3.3.1.2. Bargaining power of buyers
      • 3.3.1.3. Threat of substitutes
      • 3.3.1.4. Threat of new entrants
      • 3.3.1.5. Competitive rivalry
    • 3.3.2. PESTEL Analysis
      • 3.3.2.1. Political & Legal Landscape
      • 3.3.2.2. Economic and Social Landscape
      • 3.3.2.3. Technological landscape

Chapter 4. Breast Imaging Market: Technology Estimates & Trend Analysis

  • 4.1. Segment Dashboard
  • 4.2. Global Breast Imaging Market Technology Movement Analysis
  • 4.3. Global Breast Imaging Market Size & Trend Analysis, by Technology, 2021 to 2033 (USD Million)
  • 4.4. Ionizing
    • 4.4.1. Ionizing market estimates and forecasts for 2021 to 2033 (USD Million)
    • 4.4.2. Full-Field Digital Mammography
      • 4.4.2.1. Full-field digital mammography market estimates and forecasts for 2021 to 2033 (USD Million)
    • 4.4.3. Analog Mammography
      • 4.4.3.1. Analog mammography market estimates and forecasts for 2021 to 2033 (USD Million)
    • 4.4.4. Positron Emission Mammography
      • 4.4.4.1. Positron emission mammography market estimates and forecasts for 2021 to 2033 (USD Million)
    • 4.4.5. Electric Impedance Tomography
      • 4.4.5.1. Electric impedance tomography market estimates and forecasts for 2021 to 2033 (USD Million)
    • 4.4.6. Cone-Beam Computed Tomography
      • 4.4.6.1. Cone-beam computed tomography market estimates and forecasts for 2021 to 2033 (USD Million)
    • 4.4.7. Positron Emission Tomography & Computed Tomography
      • 4.4.7.1. Positron emission tomography & computed tomography market estimates and forecasts for 2021 to 2033 (USD Million)
    • 4.4.8. 3D Breast Tomosynthesis
      • 4.4.8.1. 3D breast tomosynthesis market estimates and forecasts for 2021 to 2033 (USD Million)
    • 4.4.9. MBI/BSGI
      • 4.4.9.1. MBI/BSGI market estimates and forecasts for 2021 to 2033 (USD Million)
  • 4.5. Non Ionizing
    • 4.5.1. Non Ionizing market estimates and forecasts for 2021 to 2033 (USD Million)
    • 4.5.2. MRI
      • 4.5.2.1. MRI market estimates and forecasts for 2021 to 2033 (USD Million)
    • 4.5.3. Thermography
      • 4.5.3.1. Thermography market estimates and forecasts for 2021 to 2033 (USD Million)
    • 4.5.4. Ultrasound
      • 4.5.4.1. Ultrasound market estimates and forecasts for 2021 to 2033 (USD Million)
    • 4.5.5. Optical Imaging
      • 4.5.5.1. Optical imaging market estimates and forecasts for 2021 to 2033 (USD Million)
    • 4.5.6. Automated Whole-Breast Ultrasound
      • 4.5.6.1. Automated whole-breast ultrasound market estimates and forecasts for 2021 to 2033 (USD Million)

Chapter 5. Breast Imaging: End Use Estimates & Trend Analysis

  • 5.1. Segment Dashboard
  • 5.2. Global Breast Imaging Market End Use Movement Analysis
  • 5.3. Global Breast Imaging Market Size & Trend Analysis, by End Use, 2021 to 2033 (USD Million)
  • 5.4. Hospitals
    • 5.4.1. Hospitals market estimates and forecasts for 2021 to 2033 (USD Million)
  • 5.5. Diagnostic Imaging Centers
    • 5.5.1. Diagnostic imaging centers market estimates and forecasts for 2021 to 2033 (USD Million)
  • 5.6. Breast Care Centers
    • 5.6.1. Breast care centers market estimates and forecasts for 2021 to 2033 (USD Million)

Chapter 6. Breast Imaging Market: Regional Estimates & Trend Analysis

  • 6.1. Regional Dashboard
  • 6.2. Market Size & Forecasts and Trend Analysis, 2021 to 2033
  • 6.3. North America
    • 6.3.1. Market estimates and forecast, 2021 - 2033 (Revenue, USD Million)
    • 6.3.2. U.S.
      • 6.3.2.1. Key country dynamics
      • 6.3.2.2. Competitive scenario
      • 6.3.2.3. Regulatory framework
      • 6.3.2.4. Reimbursement scenario
      • 6.3.2.5. U.S. market estimates and forecasts, 2021 - 2033
    • 6.3.3. Canada
      • 6.3.3.1. Key country dynamics
      • 6.3.3.2. Competitive scenario
      • 6.3.3.3. Regulatory framework
      • 6.3.3.4. Reimbursement scenario
      • 6.3.3.5. Canada market estimates and forecasts, 2021 - 2033
    • 6.3.4. Mexico
      • 6.3.4.1. Key country dynamics
      • 6.3.4.2. Competitive scenario
      • 6.3.4.3. Regulatory framework
      • 6.3.4.4. Reimbursement scenario
      • 6.3.4.5. Mexico market estimates and forecasts, 2021 - 2033
  • 6.4. Europe
    • 6.4.1. UK
      • 6.4.1.1. Key country dynamics
      • 6.4.1.2. Competitive scenario
      • 6.4.1.3. Regulatory framework
      • 6.4.1.4. Reimbursement scenario
      • 6.4.1.5. UK market estimates and forecasts, 2021 - 2033
    • 6.4.2. Germany
      • 6.4.2.1. Key country dynamics
      • 6.4.2.2. Competitive scenario
      • 6.4.2.3. Regulatory framework
      • 6.4.2.4. Reimbursement scenario
      • 6.4.2.5. Germany market estimates and forecasts, 2021 - 2033
    • 6.4.3. France
      • 6.4.3.1. Key country dynamics
      • 6.4.3.2. Competitive scenario
      • 6.4.3.3. Regulatory framework
      • 6.4.3.4. Reimbursement scenario
      • 6.4.3.5. France market estimates and forecasts, 2021 - 2033
    • 6.4.4. Italy
      • 6.4.4.1. Key country dynamics
      • 6.4.4.2. Competitive scenario
      • 6.4.4.3. Regulatory framework
      • 6.4.4.4. Reimbursement scenario
      • 6.4.4.5. Italy market estimates and forecasts, 2021 - 2033
    • 6.4.5. Spain
      • 6.4.5.1. Key country dynamics
      • 6.4.5.2. Competitive scenario
      • 6.4.5.3. Regulatory framework
      • 6.4.5.4. Reimbursement scenario
      • 6.4.5.5. Spain market estimates and forecasts, 2021 - 2033
    • 6.4.6. Denmark
      • 6.4.6.1. Key country dynamics
      • 6.4.6.2. Competitive scenario
      • 6.4.6.3. Regulatory framework
      • 6.4.6.4. Reimbursement scenario
      • 6.4.6.5. Denmark market estimates and forecasts, 2021 - 2033
    • 6.4.7. Sweden
      • 6.4.7.1. Key country dynamics
      • 6.4.7.2. Competitive scenario
      • 6.4.7.3. Regulatory framework
      • 6.4.7.4. Reimbursement scenario
      • 6.4.7.5. Sweden market estimates and forecasts, 2021 - 2033
    • 6.4.8. Norway
      • 6.4.8.1. Key country dynamics
      • 6.4.8.2. Competitive scenario
      • 6.4.8.3. Regulatory framework
      • 6.4.8.4. Reimbursement scenario
      • 6.4.8.5. Norway market estimates and forecasts, 2021 - 2033
  • 6.5. Asia Pacific
    • 6.5.1. Japan
      • 6.5.1.1. Key country dynamics
      • 6.5.1.2. Competitive scenario
      • 6.5.1.3. Regulatory framework
      • 6.5.1.4. Reimbursement scenario
      • 6.5.1.5. Japan market estimates and forecasts, 2021 - 2033
    • 6.5.2. India
      • 6.5.2.1. Key country dynamics
      • 6.5.2.2. Competitive scenario
      • 6.5.2.3. Regulatory framework
      • 6.5.2.4. Reimbursement scenario
      • 6.5.2.5. India market estimates and forecasts, 2021 - 2033
    • 6.5.3. China
      • 6.5.3.1. Key country dynamics
      • 6.5.3.2. Competitive scenario
      • 6.5.3.3. Regulatory framework
      • 6.5.3.4. Reimbursement scenario
      • 6.5.3.5. China market estimates and forecasts, 2021 - 2033
    • 6.5.4. South Korea
      • 6.5.4.1. Key country dynamics
      • 6.5.4.2. Competitive scenario
      • 6.5.4.3. Regulatory framework
      • 6.5.4.4. Reimbursement scenario
      • 6.5.4.5. South Korea market estimates and forecasts, 2021 - 2033
    • 6.5.5. Australia
      • 6.5.5.1. Key country dynamics
      • 6.5.5.2. Competitive scenario
      • 6.5.5.3. Regulatory framework
      • 6.5.5.4. Reimbursement scenario
      • 6.5.5.5. Australia market estimates and forecasts, 2021 - 2033
    • 6.5.6. Thailand
      • 6.5.6.1. Key country dynamics
      • 6.5.6.2. Competitive scenario
      • 6.5.6.3. Regulatory framework
      • 6.5.6.4. Reimbursement scenario
      • 6.5.6.5. Thailand market estimates and forecasts, 2021 - 2033
  • 6.6. Latin America
    • 6.6.1. Brazil
      • 6.6.1.1. Key country dynamics
      • 6.6.1.2. Competitive scenario
      • 6.6.1.3. Regulatory framework
      • 6.6.1.4. Reimbursement scenario
      • 6.6.1.5. Brazil market estimates and forecasts, 2021 - 2033
    • 6.6.2. Argentina
      • 6.6.2.1. Key country dynamics
      • 6.6.2.2. Competitive scenario
      • 6.6.2.3. Regulatory framework
      • 6.6.2.4. Reimbursement scenario
      • 6.6.2.5. Argentina market estimates and forecasts, 2021 - 2033
  • 6.7. MEA
    • 6.7.1. South Africa
      • 6.7.1.1. Key country dynamics
      • 6.7.1.2. Competitive scenario
      • 6.7.1.3. Regulatory framework
      • 6.7.1.4. Reimbursement scenario
      • 6.7.1.5. South Africa market estimates and forecasts, 2021 - 2033
    • 6.7.2. Saudi Arabia
      • 6.7.2.1. Key country dynamics
      • 6.7.2.2. Competitive scenario
      • 6.7.2.3. Regulatory framework
      • 6.7.2.4. Reimbursement scenario
      • 6.7.2.5. Saudi Arabia market estimates and forecasts, 2021 - 2033
    • 6.7.3. UAE
      • 6.7.3.1. Key country dynamics
      • 6.7.3.2. Competitive scenario
      • 6.7.3.3. Regulatory framework
      • 6.7.3.4. Reimbursement scenario
      • 6.7.3.5. UAE market estimates and forecasts, 2021 - 2033
    • 6.7.4. Kuwait
      • 6.7.4.1. Key country dynamics
      • 6.7.4.2. Competitive scenario
      • 6.7.4.3. Regulatory framework
      • 6.7.4.4. Reimbursement scenario
      • 6.7.4.5. Kuwait market estimates and forecasts, 2021 - 2033

Chapter 7. Competitive Landscape

  • 7.1. Recent Developments & Impact Analysis, By Key Market Participants
  • 7.2. Company/Competition Categorization
    • 7.2.1. Innovators
  • 7.3. Vendor Landscape
    • 7.3.1. List of key distributors and channel partners
    • 7.3.2. Key customers
    • 7.3.3. Global Key company market share analysis, 2024
    • 7.3.4. GE HealthCare
      • 7.3.4.1. Company overview
      • 7.3.4.2. Financial performance
      • 7.3.4.3. Product benchmarking
      • 7.3.4.4. Strategic initiatives
    • 7.3.5. Siemens Healthineers
      • 7.3.5.1. Company overview
      • 7.3.5.2. Financial performance
      • 7.3.5.3. Product benchmarking
      • 7.3.5.4. Strategic initiatives
    • 7.3.6. Philips Healthcare
      • 7.3.6.1. Company overview
      • 7.3.6.2. Financial performance
      • 7.3.6.3. Product benchmarking
      • 7.3.6.4. Strategic initiatives
    • 7.3.7. Hologic, Inc.
      • 7.3.7.1. Company overview
      • 7.3.7.2. Financial performance
      • 7.3.7.3. Product benchmarking
      • 7.3.7.4. Strategic initiatives
    • 7.3.8. Fujifilm Holdings Corp.
      • 7.3.8.1. Company overview
      • 7.3.8.2. Financial performance
      • 7.3.8.3. Product benchmarking
      • 7.3.8.4. Strategic initiatives
    • 7.3.9. SonoCine, Inc.
      • 7.3.9.1. Company overview
      • 7.3.9.2. Financial performance
      • 7.3.9.3. Product benchmarking
      • 7.3.9.4. Strategic initiatives
    • 7.3.10. Toshiba Corporation (Canon Inc.)
      • 7.3.10.1. Company overview
      • 7.3.10.2. Financial performance
      • 7.3.10.3. Product benchmarking
      • 7.3.10.4. Strategic initiatives
    • 7.3.11. Dilon Technologies, Inc.
      • 7.3.11.1. Company overview
      • 7.3.11.2. Financial performance
      • 7.3.11.3. Product benchmarking
      • 7.3.11.4. Strategic initiatives
    • 7.3.12. SonoCine, Inc.
      • 7.3.12.1. Company overview
      • 7.3.12.2. Financial performance
      • 7.3.12.3. Product benchmarking
      • 7.3.12.4. Strategic initiatives
    • 7.3.13. Aurora Imaging Technology, Inc.
      • 7.3.13.1. Company overview
      • 7.3.13.2. Financial performance
      • 7.3.13.3. Product benchmarking
      • 7.3.13.4. Strategic initiatives
  • 7.4. Heat Map Analysis/ Company Market Position Analysis
  • 7.5. Estimated Company Market Share Analysis, 2025
  • 7.6. List of Other Key Market Players

List of Tables

  • Table 1 List of secondary sources
  • Table 2 List of abbreviation
  • Table 3 North America breast imaging market, by country, 2021 - 2033 (USD million)
  • Table 4 North America breast imaging market, by technology, 2021 - 2033 (USD million)
  • Table 5 North America breast imaging market, by end use, 2021 - 2033 (USD million)
  • Table 6 U.S breast imaging market, by technology, 2021 - 2033 (USD million)
  • Table 7 U.S breast imaging market, by end use, 2021 - 2033 (USD million)
  • Table 8 Canada breast imaging market, by technology, 2021 - 2033 (USD million)
  • Table 9 Canada breast imaging market, by end use, 2021 - 2033 (USD million)
  • Table 10 Mexico breast imaging market, by technology, 2021 - 2033 (USD million)
  • Table 11 Mexcio breast imaging market, by end use, 2021 - 2033 (USD million)
  • Table 12 Europe breast imaging market, by country, 2021 - 2033 (USD million)
  • Table 13 Europe breast imaging market, by technology, 2021 - 2033 (USD million)
  • Table 14 Europe breast imaging market, by end use, 2021 - 2033 (USD million)
  • Table 15 UK breast imaging market, by technology, 2021 - 2033 (USD million)
  • Table 16 UK breast imaging market, by end use, 2021 - 2033 (USD million)
  • Table 17 Germany breast imaging market, by technology, 2021 - 2033 (USD million)
  • Table 18 Germany breast imaging market, by end use, 2021 - 2033 (USD million)
  • Table 19 France breast imaging market, by technology, 2021 - 2033 (USD million)
  • Table 20 France breast imaging market, by end use, 2021 - 2033 (USD million)
  • Table 21 Italy breast imaging market, by technology, 2021 - 2033 (USD million)
  • Table 22 Italy breast imaging market, by end use, 2021 - 2033 (USD million)
  • Table 23 Spain breast imaging market, by technology, 2021 - 2033 (USD million)
  • Table 24 Spain breast imaging market, by end use, 2021 - 2033 (USD million)
  • Table 25 Sweden breast imaging market, by technology, 2021 - 2033 (USD million)
  • Table 26 Sweden breast imaging market, by end use, 2021 - 2033 (USD million)
  • Table 27 Denmark breast imaging market, by technology, 2021 - 2033 (USD million)
  • Table 28 Denmark breast imaging market, by end use, 2021 - 2033 (USD million)
  • Table 29 Norway breast imaging market, by technology, 2021 - 2033 (USD million)
  • Table 30 Norway breast imaging market, by end use, 2021 - 2033 (USD million)
  • Table 31 Asia Pacific breast imaging market, by country, 2021 - 2033 (USD million)
  • Table 32 Asia Pacific breast imaging market, by technology, 2021 - 2033 (USD million)
  • Table 33 Asia Pacific breast imaging market, by end use, 2021 - 2033 (USD million)
  • Table 34 Japan breast imaging market, by technology, 2021 - 2033 (USD million)
  • Table 35 Japan breast imaging market, by end use, 2021 - 2033 (USD million)
  • Table 36 China breast imaging market, by technology, 2021 - 2033 (USD million)
  • Table 37 China breast imaging market, by end use, 2021 - 2033 (USD million)
  • Table 38 India breast imaging market, by technology, 2021 - 2033 (USD million)
  • Table 39 India breast imaging market, by end use, 2021 - 2033 (USD million)
  • Table 40 Australia breast imaging market, by technology, 2021 - 2033 (USD million)
  • Table 41 Australia breast imaging market, by end use, 2021 - 2033 (USD million)
  • Table 42 South Korea breast imaging market, by technology, 2021 - 2033 (USD million)
  • Table 43 South Korea breast imaging market, by end use, 2021 - 2033 (USD million)
  • Table 44 Thailand breast imaging market, by technology, 2021 - 2033 (USD million)
  • Table 45 Thailand breast imaging market, by end use, 2021 - 2033 (USD million)
  • Table 46 Latin America breast imaging market, by country, 2021 - 2033 (USD million)
  • Table 47 Latin America breast imaging market, by technology, 2021 - 2033 (USD million)
  • Table 48 Latin America breast imaging market, by end use, 2021 - 2033 (USD million)
  • Table 49 Brazil breast imaging market, by technology, 2021 - 2033 (USD million)
  • Table 50 Brazil breast imaging market, by end use, 2021 - 2033 (USD million)
  • Table 51 Argentina breast imaging market, by technology, 2021 - 2033 (USD million)
  • Table 52 Argentina breast imaging market, by end use, 2021 - 2033 (USD million)
  • Table 53 Middle East & Africa breast imaging market, by country, 2021 - 2033 (USD million)
  • Table 54 Middle East & Africa breast imaging market, by technology, 2021 - 2033 (USD million)
  • Table 55 Middle East & Africa breast imaging market, by end use, 2021 - 2033 (USD million)
  • Table 56 South Africa breast imaging market, by technology, 2021 - 2033 (USD million)
  • Table 57 South Africa breast imaging market, by end use, 2021 - 2033 (USD million)
  • Table 58 Saudi Arabia breast imaging market, by technology, 2021 - 2033 (USD million)
  • Table 59 Saudi Arabia breast imaging market, by end use, 2021 - 2033 (USD million)
  • Table 60 UAE breast imaging market, by technology, 2021 - 2033 (USD million)
  • Table 61 UAE breast imaging market, by end use, 2021 - 2033 (USD million)
  • Table 62 Kuwait breast imaging market, by technology, 2021 - 2033 (USD million)
  • Table 63 Kuwait breast imaging market, by end use, 2021 - 2033 (USD million)

List of Figures

  • Fig. 1 Breast imaging market segmentation
  • Fig. 2 Market research process
  • Fig. 3 Information procurement
  • Fig. 4 Primary research pattern
  • Fig. 5 Market research approaches
  • Fig. 6 Value chain based sizing & forecasting
  • Fig. 7 QFD modelling for market share assessment
  • Fig. 8 Market formulation & validation
  • Fig. 9 Market summary (2025)
  • Fig. 10 Penetration & growth prospect mapping
  • Fig. 11 Reimbursement pathway
  • Fig. 12 Market driver relevance analysis (Current & future impact)
  • Fig. 13 Market restraint relevance analysis (Current & future impact)
  • Fig. 14 SWOT analysis, by factor (political & legal, economic and technological)
  • Fig. 15 Porter's five forces analysis
  • Fig. 16 Breast imaging market: Technology movement analysis
  • Fig. 17 Breast imaging market technology outlook: Key takeaways
  • Fig. 18 Ionizing market, 2021 - 2033 (USD Million)
  • Fig. 19 Full-field digital mammography market, 2021 - 2033 (USD Million)
  • Fig. 20 Analog mammography market, 2021 - 2033 (USD Million)
  • Fig. 21 Positron emission mammography market, 2021 - 2033 (USD Million)
  • Fig. 22 Electric impedance tomography market, 2021 - 2033 (USD Million)
  • Fig. 23 Cone-beam computed tomography market, 2021 - 2033 (USD Million)
  • Fig. 24 Positron emission tomography & computed tomography market, 2021 - 2033 (USD Million)
  • Fig. 25 3D breast tomosynthesis market, 2021 - 2033 (USD Million)
  • Fig. 26 MBI/BSGI market, 2021 - 2033 (USD Million)
  • Fig. 27 Non Ionizing market, 2021 - 2033 (USD Million)
  • Fig. 28 MRI market, 2021 - 2033 (USD Million)
  • Fig. 29 Thermography market, 2021 - 2033 (USD Million)
  • Fig. 30 Ultrasound market, 2021 - 2033 (USD Million)
  • Fig. 31 Optical imaging market, 2021 - 2033 (USD Million)
  • Fig. 32 Automated whole-breast ultrasound market, 2021 - 2033 (USD Million)
  • Fig. 33 Breast imaging market: End use movement analysis
  • Fig. 34 Breast imaging market end use outlook: Key takeaways
  • Fig. 35 Ionizing market, 2021 - 2033 (USD Million)
  • Fig. 36 Hospitals market, 2021 - 2033 (USD Million)
  • Fig. 37 Diagnostic imaging centers market, 2021 - 2033 (USD Million)
  • Fig. 38 Breast care centers market, 2021 - 2033 (USD Million)
  • Fig. 39 Regional Outlook, 2025 & 2033
  • Fig. 40 Regional market: Key takeaways
  • Fig. 41 North America breast imaging market, 2021 - 2033 (USD Million)
  • Fig. 42 U.S. breast imaging market, 2021 - 2033 (USD Million)
  • Fig. 43 Canada breast imaging market, 2021 - 2033 (USD Million)
  • Fig. 44 Europe breast imaging market, 2021 - 2033 (USD Million)
  • Fig. 45 UK breast imaging market, 2021 - 2033 (USD Million)
  • Fig. 46 Germany breast imaging market, 2021 - 2033 (USD Million)
  • Fig. 47 France breast imaging market, 2021 - 2033 (USD Million)
  • Fig. 48 Italy breast imaging market, 2021 - 2033 (USD Million)
  • Fig. 49 Spain breast imaging market, 2021 - 2033 (USD Million)
  • Fig. 50 Sweden breast imaging market, 2021 - 2033 (USD Million)
  • Fig. 51 Denmark breast imaging market, 2021 - 2033 (USD Million)
  • Fig. 52 Norway breast imaging market, 2021 - 2033 (USD Million)
  • Fig. 53 Asia Pacific breast imaging market, 2021 - 2033 (USD Million)
  • Fig. 54 Japan breast imaging market, 2021 - 2033 (USD Million)
  • Fig. 55 China breast imaging market, 2021 - 2033 (USD Million)
  • Fig. 56 India breast imaging market, 2021 - 2033 (USD Million)
  • Fig. 57 Australia breast imaging market, 2021 - 2033 (USD Million)
  • Fig. 58 South Korea breast imaging market, 2021 - 2033 (USD Million)
  • Fig. 59 Thailand breast imaging market, 2021 - 2033 (USD Million)
  • Fig. 60 Latin America breast imaging market, 2021 - 2033 (USD Million)
  • Fig. 61 Brazil breast imaging market, 2021 - 2033 (USD Million)
  • Fig. 62 Mexico breast imaging market, 2021 - 2033 (USD Million)
  • Fig. 63 Argentina breast imaging market, 2021 - 2033 (USD Million)
  • Fig. 64 Middle East & Africa breast imaging market, 2021 - 2033 (USD Million)
  • Fig. 65 South Africa breast imaging market, 2021 - 2033 (USD Million)
  • Fig. 66 Saudi Arabia breast imaging market, 2021 - 2033 (USD Million)
  • Fig. 67 UAE breast imaging market, 2021 - 2033 (USD Million)
  • Fig. 68 Kuwait breast imaging market, 2021 - 2033 (USD Million)